N

NEUVOGEN, Inc.

14 employees

NEUVOGEN is applying a systems biology approach to develop whole-cell therapeutic cancer vaccines.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
whole cell cancer vaccines
cancer
Immunoncology
research
biotechnology
systems approach
transformative therapies
Health Care
innovation
Therapeutics
solid tumor

FAQ